Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3136217 | 0.78 | ALDH1A1 (0.36) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL3140089 | 0.78 | ALDH1A1 (0.36) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL129762 | 0.73 | ACHE (0.57) | ALDH1A1ACHETDP1CYP3A4MAPT | |
| SCHEMBL10030804 | 0.73 | ACHE (0.43) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL28929310 | 0.72 | ACHE (0.39) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL2955343 | 0.70 | ALDH1A1 (0.56) | ALDH1A1ACHECYP3A4CA9CA2 | |
| Bromide SCHEMBL8159834 | 0.70 | ALDH1A1 (0.37) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL10319558 | 0.69 | CA1 (0.32) | CA2 | |
| SCHEMBL8254929 | 0.69 | ACHE (0.46) | ALDH1A1ACHETDP1DHFRCYP3A4 | |
| SCHEMBL9768514 | 0.69 | TDP1 (0.59) | ALDH1A1ACHETDP1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7671225-B2 | Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts | UMICORE AG & CO. KG (DE) | 2010-03-02 | — | — | US | disclosed |
| US-20080287698-A1 | Ferrocenyl Ligands For Homogeneous, Enantioselective Hydrogenation Catalysts | UMICORE AG & CO. KG (DE) | 2008-11-20 | — | — | US | disclosed |
| EP-1756131-B1 | FERROCENYL LIGANDS FOR HOMOGENEOUS, ENANTIOSELECTIVE HYDROGENATION CATALYSTS | UMICORE AG & CO KG (DE) | 2007-11-28 | — | — | EP | disclosed |
| EP-1756131-A2 | FERROCENYL LIGANDS FOR HOMOGENEOUS, ENANTIOSELECTIVE HYDROGENATION CATALYSTS | Umicore AG & Co. KG (DE) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005108409-A2 | FERROCENYL LIGANDS FOR HOMOGENEOUS, ENANTIOSELECTIVE HYDROGENATION CATALYSTS | UMICORE AG & CO. KG (DE) | 2005-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287698-A1 | Ferrocenyl Ligands For Homogeneous, Enantioselective Hydrogenation Catalysts | FTH1, H1-0, HRH3 | ACHE 3912/4885ALDH1A1 3205/4885TDP1 4761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.